KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Enterprise Value (2016 - 2025)

Amgen (AMGN) has 17 years of Enterprise Value data on record, last reported at -$9.4 billion in Q3 2025.

  • For Q3 2025, Enterprise Value fell 4.82% year-over-year to -$9.4 billion; the TTM value through Dec 2025 reached -$13.2 billion, down 10.31%, while the annual FY2024 figure was -$12.0 billion, 9.4% down from the prior year.
  • Enterprise Value reached -$9.4 billion in Q3 2025 per AMGN's latest filing, down from -$8.0 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$6.5 billion in Q1 2022 and bottomed at -$34.7 billion in Q3 2023.
  • Average Enterprise Value over 5 years is -$13.7 billion, with a median of -$9.4 billion recorded in 2025.
  • Peak YoY movement for Enterprise Value: crashed 382.89% in 2023, then surged 74.03% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$8.0 billion in 2021, then fell by 15.78% to -$9.3 billion in 2022, then fell by 17.61% to -$10.9 billion in 2023, then fell by 9.4% to -$12.0 billion in 2024, then increased by 21.11% to -$9.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$9.4 billion in Q3 2025, -$8.0 billion in Q2 2025, and -$8.8 billion in Q1 2025.